1. Marzouk,
H. M., Rezk, M. R., Gouda, A. S., & Abdel-Megied, A. M. (2022). A novel
stability-indicating HPLC-DAD method for determination of favipiravir, a
potential antiviral drug for COVID-19 treatment; application to degradation
kinetic studies and in-vitro dissolution profiling. Microchemical Journal, 172,
106927.
2. Balu,
P. A., & Paresh, M. S. (2021). Stability-indicating RP HPLC method
development for estimation of favipiravir in bulk and pharmaceutical dosage
form. World Journal of Pharmaceutical Research, 10(14), 1444– 1465.
3. Blessy,
M. R., Patel, R. D., Prajapati, P. N., & Agrawal, Y. K. (2014). Development
of forced degradation and stability indicating studies of drugs-a review.
Journal of Pharmaceutical Analysis, 4(3), 159–165. https://doi.org/10.1016/j.jpha.2013.09.003
4. Nazifa
Sabir Ali, S., Mobina, L., Mehfuza, M., Seema, P., Ahmed, A., & Khan, J. G.
(2021). Analytical method development and validation and forced degradation
stability-indicating studies of favipiravir by RP-HPLC and UV in bulk and
pharmaceutical dosage form. Journal of Pharmaceutical Research International,
33, 254–271.
5. Murthy,
M. V., Krishnaiah, C., Srinivas, K., Rao, K. S., Kumar, N. R., & Mukkanti,
K. (2013). Development and validation of the RP-UPLC method for the
determination of darifenacin hydrobromide, its related compounds, and its
degradation products using the design of experiments. Journal of Pharmaceutical
and Biomedical Analysis, 72, 40–50.
6. Saranjit,
S., Mahendra, J., Gajanan, M., Harsita, T., Moolchand, K., Neha, P., &
Padmaja, S. (2013). Forced degradation studies to assess the stability of drugs
and products. Trends in Analytical Chemistry, 49, 71–88.
7. Pallavi,
V., Kamalkishor, D., & G. (2021). Bioanalytical method development and
validation for the determination of Favipiravir in spiked human plasma by using
RP-HPLC. Journal of Pharmaceutical Research International, 33, 275–281.
8. Divya
Kumar Vemuri, Rambabu Gundla, Naresh Konduru, Ravindra Mallavarapu, Naresh
Kumar Katari, Favipiravir (SARS-CoV-2) degradation impurities: Identification
and route of degradation mechanism in the finished solid dosage form using
LC/LC–MS method. Biomedical Chromatography. 2022;36: e5363. https://doi.org/10.1002/bmc.5363.
9. West
C, Lemasson E, Bertin S, Hennig P, Lesellier E. The interest of achiral-achiral
tandem columns for impurity profiling of synthetic drugs with supercritical
fluid chromatography. Journal of Chromatography A. 2018;1534(1):161-9.
10. Zeshan Aqeel, J Preston, Phil Koerner. HPLC
Column Screening for Favipiravir on Six Different 100 x 4.6 mm
Columns.Phenomenexbreakingwith traditions.2020;1;1-3.
11. Jyothi
and Kavya. Ultraviolet Spectrophotometric Method Development for Estimation of
New Antiviral Repurposing Drug Favipiravir.Asian J Pharm Clin.
Res.2021;14(7):67-69.
12. Bulduk
İ. HPLC-UV method for quantification of favipiravir in pharmaceutical
formulations. ActaChromatogr. 2021;33(3):209-15.
13. Nadendla
R, Abhinandana P. Validated High-Performance Liquid Chromatographic Method for
the Quantification of Favipiravir by PDA Detector. (2021). Int. J. Life Sci.
Pharma Res. 2021;11(2):181-188.
14. Baokar S, Mulgund S, Ranpise N. Development
and Validation of RP-HPLC Method for Simultaneous Estimation of Vildagliptin and
Metformin. Res J Pharm Dos Forms Technol. 2013;5(2):95–8.
15. Bharti
Mittu AC, Chauhan P. Analytical Method Development and Validation: A Concise
Review. J Anal Bioanal Tech. 2015;06(01):1-5